News & Events

Last week, we were thrilled to have David Walker, MSc, MBA, our VP of Life Sciences Business, represent Quantori at this year’s BioIT World Conference & Expo!

In his session, “From LLMs to Multi-Agent Systems: Advancing AI-Powered R&D in Pharma and Biotech,” David shared how leading pharma and biotech organizations transform their R&D capabilities with next-generation AI.

Key takeaways:

• Data silos, multimodal data complexity, and time-consuming manual workflows still hamper Pharma R&D.
• Large Language Models (LLMs) are helping close the gap between the explosion of biomedical data and scientists’ ability to process it.
• LLMs are now embedded into R&D workflows for target identification, biomarker discovery, and clinical trial planning.
• Multi-agent AI systems are emerging as scalable, modular platforms that improve validation, extensibility, and collaboration. Critical success factors for BioPharma include:

· High-quality data and governance
· Iterative prototyping of RAG applications
· Multi-agent orchestration and collaboration
· Robust monitoring and maintenance
· Cross-functional team alignment and stakeholder buy-in

At Quantori, we combine the expertise of PhD scientists, AI/ML engineers, full-stack developers, data engineers, and cloud architects to deliver scalable, enterprise-grade AI solutions for life sciences.

The message was clear: This is a pivotal moment for Pharma R&D. Industry leaders must now invest in scalable AI platforms, modular architectures, and organizational data readiness.

Thank you to everyone who attended the session and stopped by our Booth 403. We’re excited to continue the conversation! If you are interested in how Quantori can accelerate your AI journey in life sciences, connect with us at contact@quantori.com, and don't forget to download David's presentation here.